Showing results (11-20 of 544) with videos related to

Sort By:
Pageof 55
Cancer Treatment Reports|August 1, 1980
Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemiaS Amadori, M Tribalto, L Pacilli, et al.
Scandinavian Journal of Haematology|April 1, 1981
Combination chemotherapy for marrow relapse in children and adolescents with acute lymphocytic leukaemiaS Amadori, M A Spiriti, G Meloni, et al.
Leukemia & Lymphoma|July 28, 2016
Combination of Cytosine-Arabinoside (ARA-C), Cyclophosphamide and Prednisone in the Treatment of B-Chronic Lymphocytic Leukemia in Advanced Stages and Progressive DiseaseG D Rossi, F R Mauro, F Pizzo, et al.
Blood|April 26, 2000
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic featuresF R Mauro, R Foa, R Cerretti, et al.
Leukemia Research|January 1, 1985
Cryopreserved autologous bone marrow infusion following high dose chemotherapy in patients with acute myeloblastic leukemia in first relapseG Meloni, P De Fabritiis, G Papa, et al.
Nouvelle Revue Francaise D'Hematologie|August 1, 1993
CD5 negative lymphocytosis mimicking typical B-chronic lymphocytic leukaemia. Description of 26 casesG De Rossi, F R Mauro, F Lo Coco, et al.
Tumori|October 31, 1983
MOPP treatment of resistant Hodgkin's disease following ABVD failureG Cimino, A P Anselmo, A Marzullo, et al.
Virchows Archiv : an International Journal of Pathology|September 19, 2000
Hodgkin/Reed-Sternberg cells and Hodgkin's disease in patients with B-cell chronic lymphocytic leukaemia: an immunohistological, molecular and clinical study of four cases suggesting a heterogeneous pathogenetic backgroundE Pescarmona, P Pignoloni, F R Mauro, et al.
Leukemia Research|January 1, 1984
Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphomaS Amadori, G Papa, G Avvisati, et al.
Cancer Investigation|January 1, 1987
Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP)C Guglielmi, S Amadori, A P Anselmo, et al.
Pageof 55